Published in Vaccine Weekly, October 7th, 1996
The objective of this randomized, double-blinded clinical comprised of approximately 100 volunteers is to determine the safety and immunogenicity of the vaccine and adjuvant combination. "Pre-clinical animal studies have demonstrated that mucosal immunity is critical to the effectiveness of oral vaccines against intestinal pathogens like Campylobacter," said Dr. Vic Esposito, Antex.
"Previously we completed a Phase...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly